PTN - PALATIN TECHNOLOGIES INC
22.445
-0.515 -2.294%
Share volume: 19,496
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$22.96
-0.52
-0.02%
View ratios
| Fiscal Date | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2024 | Q2 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 02-14-2024 | 05-15-2024 | 01-07-2025 | 11-14-2024 | 02-13-2025 | 11-14-2025 | 02-17-2026 | |
| Total revenue | 2.034 M | 0.000 | 350.000 K | 0.000 | 0.000 | 8.848 M | 116.036 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 2.034 M | 0.000 | 350.000 K | 0.000 | 0.000 | 8.848 M | 116.036 K | |
| -100.00% | inf% | -100.00% | nan% | inf% | -98.69% | |||
| Operating expenses | 8.587 M | 9.193 M | 8.676 M | 7.765 M | 5.111 M | 4.186 M | 7.445 M | |
| Selling general and admin | 3.033 M | 2.033 M | 4.004 M | 2.021 M | 1.682 M | 1.661 M | 3.125 M | |
| Research and development | 5.554 M | 7.160 M | 4.672 M | 5.744 M | 3.429 M | 2.526 M | 4.320 M | |
| Total expenses | 8.587 M | 9.168 M | 8.742 M | 7.765 M | 5.111 M | 4.186 M | 7.445 M | |
| 6.77% | -4.64% | -11.18% | -34.17% | -18.09% | 77.82% | |||
| Operating income | 1.173 M | -9.218 M | -8.342 M | -7.765 M | -2.611 M | 4.661 M | -7.329 M | |
| Ebit | -7.904 M | -8.574 M | -7.669 M | 0.000 | -2.468 M | 4.661 M | -7.329 M | |
| Pretax income | -15.570 M | -8.436 M | -7.568 M | -7.824 M | -4.942 M | 4.678 M | -7.264 M | |
| -45.82% | -10.29% | 3.38% | -36.83% | -194.64% | -255.29% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -7.844 M | -8.436 M | -7.568 M | -7.824 M | -2.442 M | 4.678 M | -7.264 M | |
| -7.54% | 10.29% | -3.38% | 68.78% | 291.51% | -255.29% |